Skip to content
AnalystLens

ExxonMobil 8-K Report, Executive Changes (Feb 28, 2024)

Reports
Leadership Changes
Filing Date
Filed February 28, 2024
Period End
February 27, 2024
Security
XOM
In the record · 2016–202610-K1110-Q338-K166

XOM filed 11 annual reports (10-K), 33 quarterly reports (10-Q) and 166 current reports (8-K) between 2016 and 2026.

  1. Leadership change8-K · Mar ’21Mar ’21
  2. Leadership change8-K · Feb ’23Feb ’23
  3. Deal closed8-K · Jul ’26Jul ’26

Summary

Summary of the 8-K filed February 28, 2024. Cited figures are marked; the original filing is the authoritative source.

ExxonMobil Corp. (XOM) announced that Dr. Susan K.

Avery has decided not to stand for re-election to the company's board of directors at the upcoming annual meeting of shareholders scheduled for May 29, 2024. This decision is stated to be for reasons unrelated to the company's operations or performance. Dr. Avery will continue to serve as a director until the annual meeting concludes.

Key Highlights

  1. Dr. Susan K. Avery will not seek re-election to the ExxonMobil Board of Directors.
  2. Dr. Avery's decision is not related to company performance or operations.
  3. Dr. Avery will continue to serve on the board until the May 29, 2024, annual meeting of shareholders.
  4. This filing pertains to a change in board composition and does not include financial performance updates.

Frequently Asked Questions

  1. Why is Dr. Susan K. Avery stepping down from the board?

    Dr. Avery has announced her intention not to stand for re-election for reasons unrelated to the company, according to the filing.

  2. When will Dr. Avery's tenure on the board officially end?

    Her tenure will conclude at the annual meeting of shareholders on May 29, 2024.

  3. Does this announcement have any implications for ExxonMobil's financial performance?

    This 8-K filing specifically addresses a change in board membership and does not contain information related to the company's financial performance or operations.